Company Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany.
It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes.
It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands.
The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015.
Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Country | Canada |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 1,621 |
CEO | David Eric Klein |
Contact Details
Address: 1 Hershey Drive Smith Falls, A6 K7A0A8 Ontario, Canada | |
Phone | 855-558-9333 |
Website | canopygrowth.com |
Stock Details
Ticker Symbol | CGC |
Exchange | NASDAQ |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001737927 |
CUSIP Number | 138035100 |
ISIN Number | CA1380357048 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
David Eric Klein | Chief Executive Officer and Director |
Judy Eunjoo Hong | Chief Financial Officer and Principal Accounting Officer |
Dr. Christelle Gedeon L.L.B., Ph.D. | Chief Legal Officer and Corporate Secretary |
Jonathan Di Tosto | Chief Operations Officer |
Thomas Shipley IV | Senior Vice President of Quality Assurance and Chief Science Officer |
Jason Green | Head of Agriculture - Hemp Division |
Chris Edwards | Chief Insights Officer |
Tara Rozalowsky | Interim Chief Product Officer |
Dave Paterson | President of Canada |
Jurgen Bickel | MD and Co-Founder of STORZ and BICKEL GmbH |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 19, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Apr 19, 2024 | 424B3 | Prospectus |
Apr 19, 2024 | 424B3 | Prospectus |
Apr 19, 2024 | 8-K | Current Report |
Apr 17, 2024 | 424B3 | Prospectus |
Apr 17, 2024 | 424B3 | Prospectus |
Apr 16, 2024 | 8-K | Current Report |
Apr 1, 2024 | 424B3 | Prospectus |
Apr 1, 2024 | 424B3 | Prospectus |
Apr 1, 2024 | 8-K | Current Report |